BioMarin Elevates Financial Aspirations Following $4.8B Acquisition of Amicus Therapeutics

BioMarin Elevates Financial Aspirations Following $4.8B Acquisition of Amicus Therapeutics

BioMarin Elevates Financial Aspirations Following $4.8B Acquisition of Amicus Therapeutics